Optometrists in Delano, CA Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Dr. Mark J Park, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 919 13th Ave, Delano, CA 93215 Phone: 661-725-3795 Fax: 661-725-3797 |
 Dr. Lori Ann Kucia-park, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 919 13th Avenue, Delano, CA 93215 Phone: 661-725-3795 Fax: 661-725-3797 |
Dr. Larry M Dedonato, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1429 Main St, Delano, CA 93215 Phone: 661-725-9771 Fax: 661-725-2403 |
News Archive
Greater use of firearms linked to higher suicide rates in rural areas
Suicide rates in rural areas of Maryland are 35-percent higher than in the state's urban settings, a disparity that can be attributed to the significantly greater use of firearms in rural settings, according to new research from the Johns Hopkins Bloomberg School of Public Health.
No link between immunizations and autism
Over the past 20 years, there has been speculation about a connection between immunizations and an increase in autism. However, a study by Mayo Clinic researchers published in the January issue of Archives of Pediatrics and Adolescent Medicine suggests the increase may be due to improved awareness, changes in diagnostic criteria and availability of services, not environmental factors or immunizations.
Cardioxyl Pharmaceuticals achieves positive results in first clinical study of CXL-1020 for ADHF
Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.
Morphogenesis announces publication of new book, Cancer Vaccines: Methods and Protocols
Drs. Michael J.P. Lawman and Patricia D. Lawman, founders of the Tampa-based biotech firm Morphogenesis Inc., announce the publication of "Cancer Vaccines: Methods and Protocols," the most definitive work to date in the promising field of cancer vaccines.
Endo International introduces topical testosterone gel, FORTESTA Gel
Endo International plc announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized generic of FORTESTA® Gel (testosterone gel) CIII.
› Verified 7 days ago
Physical Therapists
Chiropractors
Optometrists
Podiatrists
Speech-Language Pathologists